MRK News

Latest MRK News

• Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why
  Solomon Oladipupo · Oct 9, 2026
• AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
  Ran Melamed · Oct 7, 2026
• RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 1, 2026
• Wall Street Analysts Are Bullish on Top Healthcare Picks
  TipRanks Newsroom · Sep 29, 2026
• Citi Remains a Hold on Merck & Company (MRK)
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 29, 2026
• Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Merck & Company (MRK)
  TipRanks Newsroom · Sep 25, 2026
• RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 24, 2026
• Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Celldex (CLDX) and Inventiva (IVA)
  TipRanks Newsroom · Sep 23, 2026
• Wall Street Analysts Are Neutral on Top Healthcare Picks
  TipRanks Newsroom · Sep 22, 2026
• Why Is Moderna Stock (MRNA) Soaring Today, September 21?
  Solomon Oladipupo · Sep 21, 2026
• Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)
  TipRanks Newsroom · Sep 21, 2026
• 3 ETFs That Could Deliver 10%+ Returns, According to the AI Analyst
  Sirisha Bhogaraju · Sep 19, 2026
• Vivmark Residential Expands Commercial Paper Program Capacity
  TipRanks Auto-Generated Newsdesk · Sep 17, 2026
• Vivmark Residential updates outlook, highlights post-merger momentum
  TipRanks Auto-Generated Newsdesk · Sep 16, 2026
• RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 15, 2026
• The Week That Was, The Week Ahead: Macro and Markets, September 13
  Sirisha Bhogaraju · Sep 13, 2026
• DBS Keeps Their Buy Rating on Merck & Company (MRK)
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 11, 2026